Drug · DIN 02510936
SUPEMTEK
PREFILLED SYRINGE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 3, 2025; first marketed October 3, 2022.
- Drug Identification Number (DIN)
- 02510936
- Company (DIN owner)
- Sanofi Vaccines Canada Ltd.Toronto, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- November 13, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H1N1) | 45 MCG | 0.5 ML |
| RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN A (H3N2) | 45 MCG | 0.5 ML |
| RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (VICTORIA) | 45 MCG | 0.5 ML |
| RECOMBINANT HAEMAGGLUTININ PROTEIN-STRAIN B (YAMAGATA) | 45 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 14, 2021: NOC 25019New Drug Submission (NDS)